Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Heron Therapeutics, Inc. HRTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.67
+597.2%

There have been 50 recent insider transactions recorded for Heron Therapeutics, Inc. (HRTX), including 26 buys and 22 sells. Total insider buying was valued at $227.08K and total insider selling at RSU Award.

Notable insiders with recent activity include Collard Craig A, Forbes William P, Duarte Ira. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — HRTX

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-04-03 Collard Craig A Chief Executive Officer Option Exercise (Sell) 62,500 - - 62,500
2026-01-31 Forbes William P EVP, Chief Development Officer Option Exercise (Sell) 11,695 - - 140,332
2026-01-31 Collard Craig A Chief Executive Officer Option Exercise (Sell) 34,789 - - 417,464
2026-01-31 Duarte Ira EVP, Chief Financial Officer Option Exercise (Sell) 11,695 - - 140,332
2026-01-30 Forbes William P EVP, Chief Development Officer RSU Award 188,314 - - 188,314
2026-01-30 Collard Craig A Chief Executive Officer RSU Award 800,336 - - 800,336
2026-01-30 Johnson Craig A Director RSU Award 53,960 - - 53,960
2026-01-30 Duarte Ira EVP, Chief Financial Officer RSU Award 216,561 - - 216,561
2026-01-30 Christian Waage Director RSU Award 53,960 - - 53,960
2026-01-30 Kaseta Michael Director RSU Award 53,960 - - 53,960
2026-01-30 Dissanaike Sharmila Director RSU Award 53,960 - - 53,960
2026-01-30 Morgan Adam Director RSU Award 53,960 - - 123,737
2026-01-30 Hensley Mark Earl Chief Operating Officer RSU Award 188,314 - - 188,314
2026-01-30 Cusack Thomas Director RSU Award 53,960 - - 53,960
2026-01-19 Forbes William P EVP, Chief Development Officer Option Exercise (Sell) 3,875 - - 30,994
2026-01-19 Collard Craig A Chief Executive Officer Option Exercise (Sell) 13,797 - - 110,375
2026-01-19 Duarte Ira EVP, Chief Financial Officer Option Exercise (Sell) 3,875 - - 30,994
2025-11-08 Cusack Thomas Director RSU Award 37,879 - - 37,879
2025-10-31 Forbes William P EVP, Chief Development Officer Option Exercise (Sell) 11,694 - - 152,027
2025-10-31 Collard Craig A Chief Executive Officer Option Exercise (Sell) 34,789 - - 452,253
2025-10-31 Duarte Ira EVP, Chief Financial Officer Option Exercise (Sell) 11,694 - - 152,027
2025-10-27 Cusack Thomas Officer Unknown - - - -
2025-10-19 Forbes William P EVP, Chief Development Officer Option Exercise (Sell) 3,874 - - 34,869
2025-10-19 Collard Craig A Chief Executive Officer Option Exercise (Sell) 13,797 - - 124,172
2025-10-19 Duarte Ira EVP, Chief Financial Officer Option Exercise (Sell) 3,874 - - 34,869
2025-10-15 Rubric Capital Management Lp 10 Percent Owner Conversion (Sell) 94,610 - - -
2025-08-08 Rubric Capital Management Lp 10 Percent Owner Informative Buy - - - -
2025-08-08 Morgan Adam Director Informative Buy 70,012 $1.50 $105.02K 70,012
2025-07-31 Forbes William P EVP, Chief Development Officer Option Exercise 11,695 - - 150,635
2025-07-31 Collard Craig A Chief Executive Officer Option Exercise 34,789 - - 474,538
2025-07-31 Duarte Ira EVP, Chief Financial Officer Option Exercise (Sell) 11,695 - - 163,721
2025-07-19 Forbes William P EVP, Chief Development Officer Option Exercise (Sell) 3,874 - - 38,743
2025-07-19 Collard Craig A Chief Executive Officer Option Exercise (Sell) 13,797 - - 137,969
2025-07-19 Duarte Ira EVP, Chief Financial Officer Option Exercise (Sell) 3,874 - - 38,743
2025-06-16 Duarte Ira EVP, Chief Financial Officer Option Exercise 12,500 - - 25,000
2025-06-06 Forbes William P EVP, Chief Development Officer Option Exercise (Sell) 12,500 - - 25,000
2025-05-06 Hensley Mark Earl Chief Operating Officer RSU Award 500,000 - - 500,000
2025-04-30 Forbes William P EVP, Chief Development Officer Option Exercise 11,694 - - 122,566
2025-04-30 Collard Craig A Chief Executive Officer Option Exercise 34,789 - - 425,952
2025-04-30 Duarte Ira EVP, Chief Financial Officer Option Exercise 11,694 - - 136,149
2025-04-28 Hensley Mark Earl Officer Unknown - - - -
2025-04-19 Forbes William P EVP, Chief Development Officer Option Exercise (Sell) 3,875 - - 42,617
2025-04-19 Collard Craig A Chief Executive Officer Option Exercise (Sell) 13,796 - - 151,766
2025-04-19 Duarte Ira EVP, Chief Financial Officer Option Exercise 3,875 - - 42,617
2025-04-03 Collard Craig A Chief Executive Officer Option Exercise (Sell) 62,500 - - 125,000
2025-01-31 Forbes William P EVP, Chief Development Officer RSU Award 187,110 - - 187,110
2025-01-31 Collard Craig A Chief Executive Officer RSU Award 556,620 - - 556,620
2025-01-31 Johnson Craig A Director RSU Award 35,900 $1.70 $61.03K 35,900
2025-01-31 Duarte Ira EVP, Chief Financial Officer RSU Award 187,110 - - 187,110
2025-01-31 Christian Waage Director RSU Award 35,900 $1.70 $61.03K 35,900
■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry

People Also View

TERN
TERN
Terns Pharmaceuticals, Inc.
$52.71
+0.06%
 DAWN
DAWN
Day One Biopharmaceuticals, Inc.
$21.47
+0.05%
 INZY
INZY
Inozyme Pharma, Inc.
$4.00
+0.25%
 ELDN
ELDN
Eledon Pharmaceuticals, Inc.
$3.30
+3.13%
 ABOS
ABOS
Acumen Pharmaceuticals, Inc.
$2.72
+1.49%
 PDSB
PDSB
PDS Biotechnology Corporation
$1.36
+28.30%
 MREO
MREO
Mereo BioPharma Group plc
$0.34
+2.98%
 XFOR
XFOR
X4 Pharmaceuticals, Inc.
$4.33
+3.10%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message